BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6608517)

  • 1. Difference in transglycosylation between human pancreatic and salivary alpha-amylases.
    Omichi K; Ikenaka T
    J Biochem; 1983 Dec; 94(6):1797-802. PubMed ID: 6608517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential assay of human pancreatic and salivary alpha-amylases in serum using a new fluorogenic substrate.
    Omichi K; Ikenaka T
    Clin Chim Acta; 1984 Apr; 138(2):197-203. PubMed ID: 6609786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential rate assay of human pancreatic and salivary alpha-amylases in serum using two coupled enzymes.
    Omichi K; Ikenaka T
    J Biochem; 1986 Nov; 100(5):1353-8. PubMed ID: 3546280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the substrate specificity of Taka-amylase A1. XIV. Preparation of 6-deoxy-6-halogenomaltotrioses and their hydrolysis by Taka-amylase A.
    Omichi K; Matsushima Y
    J Biochem; 1978 Oct; 84(4):835-41. PubMed ID: 309468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New enzymatic synthesis of 6(3)-modified maltooligosaccharides and their inhibitory activities for human alpha-amylases.
    Uchida R; Nasu A; Tokutake S; Kasai K; Tobe K; Yamaji N
    Carbohydr Res; 1998 Feb; 307(1-2):69-76. PubMed ID: 9658564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-amylase assay with use of a benzyl derivative of p-nitrophenyl alpha-maltopentaoside, BG5P.
    Satomura S; Sakata Y; Omichi K; Ikenaka T
    Clin Chim Acta; 1988 Jun; 174(3):315-23. PubMed ID: 3134147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inspection of active sites of human salivary alpha-amylase isozymes by means of non-reducing-end substituted maltooligosaccharides with 2-pyridylamino residue.
    Omichi K; Ikenaka T
    J Biochem; 1986 Apr; 99(4):1245-52. PubMed ID: 3486866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of aglycone-binding site of human salivary alpha-amylase by means of transglycosylation reactions.
    Omichi K; Hase S; Ikenaka T
    J Biochem; 1991 Mar; 109(3):410-5. PubMed ID: 1880127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of non-reducing-end substituted p-nitrophenyl alpha-maltopentaoside (FG5P) as a substrate for a coupled enzymatic assay for alpha-amylases.
    Omichi K; Ikenaka T
    J Biochem; 1985 Apr; 97(4):977-82. PubMed ID: 3161874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of a new fluorogenic substrate of alpha-amylases and a simple alpha-amylase assay by HPLC.
    Omichi K; Ikenaka T
    J Biochem; 1983 Apr; 93(4):1055-60. PubMed ID: 6190796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of p-nitrophenyl 6(5)-O-benzyl-alpha-maltopentaoside, a substrate for alpha amylases.
    Satomura S; Iwata T; Sakata Y; Omichi K; Ikenaka T
    Carbohydr Res; 1988 May; 176(1):107-15. PubMed ID: 3261202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses of subtractively modified 2-chloro-4-nitrophenyl beta-maltopentaosides and their application to the differential assay of human alpha-amylases.
    Tokutake S; Oguma T; Tobe K; Kotani K; Saito K; Yamaji N
    Carbohydr Res; 1993 Jan; 238():193-213. PubMed ID: 8431933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the active site of Taka-amylase A: its action on phenyl maltooligosides with a charge at their non-reducing-ends.
    Nagamine Y; Sumikawa M; Omichi K; Ikenaka T
    J Biochem; 1987 Oct; 102(4):767-75. PubMed ID: 3501785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses of 2-chloro-4-nitrophenyl beta-D-maltopentaosides with bulky modification and their application to the differential assay of human alpha-amylases.
    Tokutake S; Kotani K; Saito K; Yamaji N
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2531-6. PubMed ID: 1446374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of human pancreatic and salivary alpha-amylases with carboxymethylamyloses as substrates.
    Satomura S; Okajima S; Hamanaka T; Shintani A; Miyashita Y; Sakata Y
    Clin Chim Acta; 1984 Mar; 138(1):21-9. PubMed ID: 6609027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of human salivary alpha-amylase isozymes by high-performance liquid chromatography with a continuous monitor system of the activity.
    Omichi K; Ikenaka T
    Anal Biochem; 1988 Feb; 168(2):332-6. PubMed ID: 3259114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of porcine pancreatic and Bacillus subtilis alpha-amylases and Aspergillus niger glucoamylase on phosphorylated (1--4)-alpha-D-glucan.
    Takeda Y; Hizukuri S; Ozono Y; Suetake M
    Biochim Biophys Acta; 1983 Dec; 749(3):302-11. PubMed ID: 6419777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic investigation of a new inhibitor for human salivary alpha-amylase.
    Kandra L; Zajácz A; Remenyik J; Gyémánt G
    Biochem Biophys Res Commun; 2005 Sep; 334(3):824-8. PubMed ID: 16023996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the substrate specificity of Taka-amylase A. XIII. Preparation of 6-deoxy-6-iodomaltooligosaccharides and their inhibitory action against Taka-amylase A1.
    Omichi K; Fujii K; Mizukami T; Matsushima Y
    J Biochem; 1978 May; 83(5):1443-7. PubMed ID: 306997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of human non-salivary, non-pancreatic alpha-amylase from salivary and pancreatic alpha-amylases by use of FG5P.
    Omichi K; Shiosaki K; Matsubara K; Ikenaka T
    J Biochem; 1990 Apr; 107(4):546-9. PubMed ID: 2358428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.